Wenyan Ren
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CD94/NKG2A-Qa-1b axis as a key modulator of vaccine responsiveness in aging populations.
Journal: Cell reports
Published: April 24, 2025
LL-37 Inhibits TMPRSS2-Mediated S2' Site Cleavage and SARS-CoV-2 Infection but Not Omicron Variants.
LL-37 Inhibits TMPRSS2-Mediated S2' Site Cleavage and SARS-CoV-2 Infection but Not Omicron Variants.
Journal: Cell proliferation
Published: February 11, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.
Journal: Nature biomedical engineering
Published: February 11, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
Journal: The Journal of clinical investigation
Published: July 28, 2023
TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway.
Journal: Journal for immunotherapy of cancer
Published: February 14, 2023
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants.
Journal: Nature communications
Published: January 03, 2023
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment.
Journal: Signal transduction and targeted therapy
Published: October 10, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant.
Journal: Nature communications
Published: April 26, 2022
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants.
Journal: Signal transduction and targeted therapy
Published: February 27, 2022
Last Updated: 09/26/2026